Skip to main content
NCBI home page
Quality & Safety in Health Care logoLink to Quality & Safety in Health Care
. 2003 Jun;12(3):176–180. doi: 10.1136/qhc.12.3.176

Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study

S Ruths 1, J Straand 1, H Nygaard 1
PMCID: PMC1743717  PMID: 12792006

Abstract

Aim: Based on a multidisciplinary review of drug use in nursing home residents, this study aimed to identify the most frequent clinically relevant medication problems and to analyse them according to the drugs involved and types of problems.

Methods: Cross sectional study auditing drug use by 1354 residents in 23 nursing homes in Bergen, Norway. Data were collected in 1997. A physician/pharmacist panel performed a comprehensive medication review with regard to indications for drug use and active medical conditions. The drug related problems were subsequently classified according to the drugs involved and types of problems (indication, effectiveness, and safety issues).

Results: 2445 potential medication problems were identified in 1036 (76%) residents. Psychoactive drugs accounted for 38% of all problems; antipsychotics were the class most often involved. Multiple psychoactive drug use was considered particularly problematic. Potential medication problems were most frequently classified as risk of adverse drug reactions (26%), inappropriate drug choice for indication (20%), and underuse of beneficial treatment (13%).

Conclusions: Three of four nursing home residents had clinically relevant medication problems, most of which were accounted for by psychoactive drugs. The most frequent concerns were related to adverse drug reactions, drug choice, and probable undertreatment.

Full Text

The Full Text of this article is available as a PDF (125.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avorn J., Gurwitz J. H. Drug use in the nursing home. Ann Intern Med. 1995 Aug 1;123(3):195–204. doi: 10.7326/0003-4819-123-3-199508010-00007. [DOI] [PubMed] [Google Scholar]
  2. Bates D. W., Cullen D. J., Laird N., Petersen L. A., Small S. D., Servi D., Laffel G., Sweitzer B. J., Shea B. F., Hallisey R. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995 Jul 5;274(1):29–34. [PubMed] [Google Scholar]
  3. Beers M. H. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med. 1997 Jul 28;157(14):1531–1536. [PubMed] [Google Scholar]
  4. Beers M. H., Ouslander J. G., Fingold S. F., Morgenstern H., Reuben D. B., Rogers W., Zeffren M. J., Beck J. C. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med. 1992 Oct 15;117(8):684–689. doi: 10.7326/0003-4819-117-8-684. [DOI] [PubMed] [Google Scholar]
  5. Beers M. H., Ouslander J. G., Rollingher I., Reuben D. B., Brooks J., Beck J. C. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med. 1991 Sep;151(9):1825–1832. [PubMed] [Google Scholar]
  6. Cooper J. W. Adverse drug reaction-related hospitalizations of nursing facility patients: a 4-year study. South Med J. 1999 May;92(5):485–490. doi: 10.1097/00007611-199905000-00007. [DOI] [PubMed] [Google Scholar]
  7. Cooper J. W. Probable adverse drug reactions in a rural geriatric nursing home population: a four-year study. J Am Geriatr Soc. 1996 Feb;44(2):194–197. doi: 10.1111/j.1532-5415.1996.tb02439.x. [DOI] [PubMed] [Google Scholar]
  8. Ebbesen J., Buajordet I., Erikssen J., Brørs O., Hilberg T., Svaar H., Sandvik L. Drug-related deaths in a department of internal medicine. Arch Intern Med. 2001 Oct 22;161(19):2317–2323. doi: 10.1001/archinte.161.19.2317. [DOI] [PubMed] [Google Scholar]
  9. Ferrell B. A. Pain evaluation and management in the nursing home. Ann Intern Med. 1995 Nov 1;123(9):681–687. doi: 10.7326/0003-4819-123-9-199511010-00007. [DOI] [PubMed] [Google Scholar]
  10. Field T. S., Gurwitz J. H., Avorn J., McCormick D., Jain S., Eckler M., Benser M., Bates D. W. Risk factors for adverse drug events among nursing home residents. Arch Intern Med. 2001 Jul 9;161(13):1629–1634. doi: 10.1001/archinte.161.13.1629. [DOI] [PubMed] [Google Scholar]
  11. Flint A. J. Choosing appropriate antidepressant therapy in the elderly. A risk-benefit assessment of available agents. Drugs Aging. 1998 Oct;13(4):269–280. doi: 10.2165/00002512-199813040-00003. [DOI] [PubMed] [Google Scholar]
  12. Furniss L., Burns A., Craig S. K., Scobie S., Cooke J., Faragher B. Effects of a pharmacist's medication review in nursing homes. Randomised controlled trial. Br J Psychiatry. 2000 Jun;176:563–567. doi: 10.1192/bjp.176.6.563. [DOI] [PubMed] [Google Scholar]
  13. Furniss L., Craig S. K., Burns A. Medication use in nursing homes for elderly people. Int J Geriatr Psychiatry. 1998 Jul;13(7):433–439. doi: 10.1002/(sici)1099-1166(199807)13:7<433::aid-gps798>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  14. Gill S. S., Misiaszek B. C., Brymer C. Improving prescribing in the elderly: a study in the long term care setting. Can J Clin Pharmacol. 2001 Summer;8(2):78–83. [PubMed] [Google Scholar]
  15. Gurwitz J. H., Field T. S., Avorn J., McCormick D., Jain S., Eckler M., Benser M., Edmondson A. C., Bates D. W. Incidence and preventability of adverse drug events in nursing homes. Am J Med. 2000 Aug 1;109(2):87–94. doi: 10.1016/s0002-9343(00)00451-4. [DOI] [PubMed] [Google Scholar]
  16. Gurwitz J. H., Soumerai S. B., Avorn J. Improving medication prescribing and utilization in the nursing home. J Am Geriatr Soc. 1990 May;38(5):542–552. doi: 10.1111/j.1532-5415.1990.tb02406.x. [DOI] [PubMed] [Google Scholar]
  17. Gurwitz Jerry H., Rochon Paula, Food and Drug Administration (U.S.) Improving the quality of medication use in elderly patients: a not-so-simple prescription. Arch Intern Med. 2002 Aug 12;162(15):1670–1672. doi: 10.1001/archinte.162.15.1670. [DOI] [PubMed] [Google Scholar]
  18. Hanlon J. T., Schmader K. E., Ruby C. M., Weinberger M. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc. 2001 Feb;49(2):200–209. doi: 10.1046/j.1532-5415.2001.49042.x. [DOI] [PubMed] [Google Scholar]
  19. Hanlon J. T., Schmader K. E., Samsa G. P., Weinberger M., Uttech K. M., Lewis I. K., Cohen H. J., Feussner J. R. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992 Oct;45(10):1045–1051. doi: 10.1016/0895-4356(92)90144-c. [DOI] [PubMed] [Google Scholar]
  20. Harrington C., Tompkins C., Curtis M., Grant L. Psychotropic drug use in long-term care facilities: a review of the literature. Gerontologist. 1992 Dec;32(6):822–833. doi: 10.1093/geront/32.6.822. [DOI] [PubMed] [Google Scholar]
  21. Hatoum H. T., Akhras K. 1993 Bibliography: a 32-year literature review on the value and acceptance of ambulatory care provided by pharmacists. Ann Pharmacother. 1993 Sep;27(9):1106–1119. doi: 10.1177/106002809302700917. [DOI] [PubMed] [Google Scholar]
  22. Leipzig R. M., Cumming R. G., Tinetti M. E. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc. 1999 Jan;47(1):30–39. doi: 10.1111/j.1532-5415.1999.tb01898.x. [DOI] [PubMed] [Google Scholar]
  23. Leipzig R. M., Cumming R. G., Tinetti M. E. Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc. 1999 Jan;47(1):40–50. doi: 10.1111/j.1532-5415.1999.tb01899.x. [DOI] [PubMed] [Google Scholar]
  24. Mannesse C. K., Derkx F. H., de Ridder M. A., Man in 't Veld A. J., van der Cammen T. J. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing. 2000 Jan;29(1):35–39. doi: 10.1093/ageing/29.1.35. [DOI] [PubMed] [Google Scholar]
  25. McLeod P. J., Huang A. R., Tamblyn R. M., Gayton D. C. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ. 1997 Feb 1;156(3):385–391. [PMC free article] [PubMed] [Google Scholar]
  26. Meyer M. C., Baldessarini R. J., Goff D. C., Centorrino F. Clinically significant interactions of psychotropic agents with antipsychotic drugs. Drug Saf. 1996 Nov;15(5):333–346. doi: 10.2165/00002018-199615050-00004. [DOI] [PubMed] [Google Scholar]
  27. Montamat S. C., Cusack B. Overcoming problems with polypharmacy and drug misuse in the elderly. Clin Geriatr Med. 1992 Feb;8(1):143–158. [PubMed] [Google Scholar]
  28. Moore A. R., O'Keeffe S. T. Drug-induced cognitive impairment in the elderly. Drugs Aging. 1999 Jul;15(1):15–28. doi: 10.2165/00002512-199915010-00002. [DOI] [PubMed] [Google Scholar]
  29. Rich M. W., Beckham V., Wittenberg C., Leven C. L., Freedland K. E., Carney R. M. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995 Nov 2;333(18):1190–1195. doi: 10.1056/NEJM199511023331806. [DOI] [PubMed] [Google Scholar]
  30. Roberts M. S., Stokes J. A., King M. A., Lynne T. A., Purdie D. M., Glasziou P. P., Wilson D. A., McCarthy S. T., Brooks G. E., de Looze F. J. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol. 2001 Mar;51(3):257–265. doi: 10.1046/j.1365-2125.2001.00347.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Rochon P. A., Gurwitz J. H. Prescribing for seniors: neither too much nor too little. JAMA. 1999 Jul 14;282(2):113–115. doi: 10.1001/jama.282.2.113. [DOI] [PubMed] [Google Scholar]
  32. Roughead E. E., Gilbert A. L., Primrose J. G., Sansom L. N. Drug-related hospital admissions: a review of Australian studies published 1988-1996. Med J Aust. 1998 Apr 20;168(8):405–408. doi: 10.5694/j.1326-5377.1998.tb138996.x. [DOI] [PubMed] [Google Scholar]
  33. Ruths S., Straand J., Nygaard H. A., Hodneland F. Drug treatment of heart failure--do nursing-home residents deserve better? Scand J Prim Health Care. 2000 Dec;18(4):226–231. doi: 10.1080/028134300448797. [DOI] [PubMed] [Google Scholar]
  34. Ruths S., Straand J., Nygaard H. A. Psychotropic drug use in nursing homes--diagnostic indications and variations between institutions. Eur J Clin Pharmacol. 2001 Sep;57(6-7):523–528. doi: 10.1007/s002280100348. [DOI] [PubMed] [Google Scholar]
  35. Schneider L. S., Pollock V. E., Lyness S. A. A metaanalysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc. 1990 May;38(5):553–563. doi: 10.1111/j.1532-5415.1990.tb02407.x. [DOI] [PubMed] [Google Scholar]
  36. Semla T. P., Palla K., Poddig B., Brauner D. J. Effect of the Omnibus Reconciliation Act 1987 on antipsychotic prescribing in nursing home residents. J Am Geriatr Soc. 1994 Jun;42(6):648–652. doi: 10.1111/j.1532-5415.1994.tb06865.x. [DOI] [PubMed] [Google Scholar]
  37. Shelton P. S., Fritsch M. A., Scott M. A. Assessing medication appropriateness in the elderly: a review of available measures. Drugs Aging. 2000 Jun;16(6):437–450. doi: 10.2165/00002512-200016060-00004. [DOI] [PubMed] [Google Scholar]
  38. Shelton P. S., Hanlon J. T., Landsman P. B., Scott M. A., Lewis I. K., Schmader K. E., Samsa G. P., Weinberger M. Reliability of drug utilization evaluation as an assessment of medication appropriateness. Ann Pharmacother. 1997 May;31(5):533–542. doi: 10.1177/106002809703100502. [DOI] [PubMed] [Google Scholar]
  39. Sørensen L., Foldspang A., Gulmann N. C., Munk-Jørgensen P. Determinants for the use of psychotropics among nursing home residents. Int J Geriatr Psychiatry. 2001 Feb;16(2):147–154. doi: 10.1002/1099-1166(200102)16:2<147::aid-gps286>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  40. Talerico Karen Amann. A critique of research measures used to assess inappropriate psychoactive drug use in older adults. J Am Geriatr Soc. 2002 Feb;50(2):374–377. doi: 10.1046/j.1532-5415.2002.50072.x. [DOI] [PubMed] [Google Scholar]
  41. Thapa P. B., Gideon P., Cost T. W., Milam A. B., Ray W. A. Antidepressants and the risk of falls among nursing home residents. N Engl J Med. 1998 Sep 24;339(13):875–882. doi: 10.1056/NEJM199809243391303. [DOI] [PubMed] [Google Scholar]
  42. Weiner D. K., Hanlon J. T., Studenski S. A. Effects of central nervous system polypharmacy on falls liability in community-dwelling elderly. Gerontology. 1998;44(4):217–221. doi: 10.1159/000022013. [DOI] [PubMed] [Google Scholar]
  43. Williams B., Betley C. Inappropriate use of nonpsychotropic medications in nursing homes. J Am Geriatr Soc. 1995 May;43(5):513–519. doi: 10.1111/j.1532-5415.1995.tb06098.x. [DOI] [PubMed] [Google Scholar]
  44. van Dijk K. N., de Vries C. S., van den Berg P. B., Brouwers J. R., de Jong-van den Berg L. T. Drug utilisation in Dutch nursing homes. Eur J Clin Pharmacol. 2000 Jan;55(10):765–771. doi: 10.1007/s002280050012. [DOI] [PubMed] [Google Scholar]
  45. van Eijk M. E., Avorn J., Porsius A. J., de Boer A. Reducing prescribing of highly anticholinergic antidepressants for elderly people: randomised trial of group versus individual academic detailing. BMJ. 2001 Mar 17;322(7287):654–657. doi: 10.1136/bmj.322.7287.654. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Quality & safety in health care are provided here courtesy of BMJ Publishing Group

RESOURCES